MIRAGEN THERAPEUTICS, INC. Uncategorized Contracts & Agreements
24 Contracts & Agreements
- Form of Indemnity Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on February 27, 2024)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2024)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 9, 2023)
- Open Market Sale Agreement (Filed With SEC on August 12, 2021)
- Open Market Sale Agreement, dated April 23, 2021, by and between Viridian Therapeutics, Inc. and Jefferies LLC (Filed With SEC on April 26, 2021)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 26, 2021)
- Amendment to Research Subaward Agreement, entered into as of August 11, 2020, by and between Registrant and Yale University (Filed With SEC on November 12, 2020)
- Deferral Agreement between Silicon Valley Bank and the Registrant effective as of April 6, 2020 (Filed With SEC on May 8, 2020)
- Amendment to Research Subaward Agreement, entered into as of April 7, 2020, by and between Registrant and Yale University (Filed With SEC on May 8, 2020)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 13, 2020)
- Amendment to Research Subaward Agreement, entered into as of October 11, 2019 and effective as of August 12, 2019, by and between Registrant and Yale University, as amended (Filed With SEC on November 8, 2019)
- Amendment to Research Subaward Agreement, entered into as of March 7, 2019 and effective as of September 1, 2018, by and between Registrant and Yale University, as amended (Filed With SEC on May 9, 2019)
- Research Subaward Agreement Amendment (Filed With SEC on May 11, 2017)
- SUBCONTRACT AGREEMENT BETWEEN YALE UNIVERSITY AND MIRAGEN THERAPEUTICS, INC. (Filed With SEC on December 2, 2016)
- NON-EMPLOYEE DIRECTOR CASH AND EQUITYCOMPENSATION POLICY (Filed With SEC on December 2, 2016)
- SECOND ADDENDUM (Filed With SEC on December 2, 2016)
- FIRST ADDENDUM (Filed With SEC on December 2, 2016)
- INDEMNITY AGREEMENT (Filed With SEC on December 2, 2016)
- SUPPORT AGREEMENT (Filed With SEC on November 1, 2016)
- SUPPORT AGREEMENT (Filed With SEC on November 1, 2016)
- UAMSBIOVENTURES LEASEAGREEMENT (Filed With SEC on March 21, 2016)
- SIGNAL GENETICS, INC. (Filed With SEC on March 27, 2015)
- SIGNAL GENETICS LLC 667 MADISON AVENUE 14TH FLOOR NEW YORK, NY 10065 October 9, 2013 (Filed With SEC on March 19, 2014)
- AMENDED AND RESTATED SECURED DEMAND PROMISSORYNOTE (Filed With SEC on March 19, 2014)
